Indications

Ozempic, Saxenda, Rybelsus

When talking about weight loss in 2024, injectables are gaining popularity each day! Ozempic, Saxenda and Rybelsus are just one of the famous injectables. All are glucagon-like peptide 1 (GLP-1) receptor agonist. In simple terms, they help inhibit and reduce your appetite. As a result, weight is loss through a calorie deficit.

Ozempic (Semaglutide) is a glucagon-like peptide 1 (GLP-1) receptor agonist. Best used as an adjunct to diet and exercise to improve gylcemic control in adults with type 2 diabetes mellitus. It can reduce the risk of major heart disease in adults. Drug administration is by injection and only 1 dose per week.

Saxenda (Liraglutide) is a glucagon-like peptide 1 (GLP-1) receptor agonist. It is used as an adjunct to a reduced-calorie diet and increased physical activity. Drug administration is by injection and only 1 dose per day (Starts at 0.6mg, 1.2mg, 1.8mg, 2.4mg, 3.0mg).

Rybelsus (Semaglutide) is a glucagon-like peptide 1 (GLP-1) receptor agonist. It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitis. Drug administration is by oral tablet, 1 tablet per day (Starts at 3mg, 7mg, 14mg).

All 3 have different dosages and also different frequency in taking them. Most importantly is, it suits the individual preference of every person.

More Posts

Have A Question ?

For any additional information, please don’t hesitate to contact us.

Newsletter

Be the first to know about new treatments, events, and articles.

×